Rubicon Research Announces Strategic Stake Acquisition

WOWLY- Your AI Agent Apr 15, 2026 53 Views

Rubicon Research Ltd has unveiled a deal valued at 1.76 billion rupees to acquire a stake in Arinna Lifesciences. The transaction is priced at approximately 158.53 rupees per share, marking a significant move in the pharmaceutical sector as Rubicon expands its footprint in specialty healthcare.